Manufactured by Novartis Pharmaceuticals Corporation, Zelnorm (known generically as Tegaserod) is used for the treatment of irritable bowel syndrome (IBS) and constipation. Zelnorm was withdrawn from the market on March 30, 2007 when the Food and Drug Administration (FDA) warned that use of Zelnorm could produce “serious adverse events.” 21 patients taking Zelnorm had experienced serious consequences of diarrhea. 20 patients had been diagnosed with ischemic colitis. 3 patients had been diagnosed with other types of intestinal ischemia. In some patients, these adverse events have led to hospitalization, surgery, and even death. Respectable sources allege that Zelnorm has been “found to increase the risk of heart attack, stroke, and worsening heart chest pain.” Due to these extremely serious complications, patients who currently take Zelnorm, or have taken this drug in the past, need to be very cautious of the serious side effects.

If you believe that Zelnorm or Tegaserod use may have put you in danger, please contact us through this website to obtain a free consultation and learn more.

"YOUR FUTURE DEPENDS ON WHAT YOU DO TODAY"
Don't let them mistreat you or your loved ones.
Just call 1-(800)-827-7898.
We are here to help you and answer your questions.